Nutex Health Inc. (NUTX)

NASDAQ: NUTX · Real-Time Price · USD
126.39
+1.69 (1.36%)
At close: May 19, 2026, 4:00 PM EDT
126.39
0.00 (0.00%)
After-hours: May 19, 2026, 4:10 PM EDT
Market Cap869.73M +37.2%
Revenue (ttm)879.95M +41.0%
Net Income96.38M +30.8%
EPS13.86 +8.7%
Shares Out 6.88M
PE Ratio9.12
Forward PE5.91
Dividendn/a
Ex-Dividend Daten/a
Volume87,208
Open123.36
Previous Close124.70
Day's Range120.55 - 127.00
52-Week Range77.21 - 193.07
Beta2.07
AnalystsStrong Buy
Price Target235.67 (+86.46%)
Earnings DateApr 30, 2026

About NUTX

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatie... [Read more]

Sector Healthcare
Founded 2011
Employees 1,005
Stock Exchange NASDAQ
Ticker Symbol NUTX
Full Company Profile

Financial Performance

In 2025, Nutex Health's revenue was $875.26 million, an increase of 82.36% compared to the previous year's $479.95 million. Earnings were $70.79 million, an increase of 35.88%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for NUTX stock is "Strong Buy." The 12-month stock price target is $235.67, which is an increase of 86.46% from the latest price.

Price Target
$235.67
(86.46% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Nutex Health Slides: Corporate presentation

Nutex Health has posted slides in relation to its latest quarterly earnings report, which was published on May 4, 2026.

15 days ago - Filings

Nutex Health Earnings Call Transcript: Q1 2026

Revenue and net income grew year-over-year, while adjusted EBITDA declined due to arbitration cost timing. Cash flow and liquidity remain strong, with new hospital openings and direct development initiatives supporting future growth. Legislative and payer dynamics continue to influence reimbursement.

18 days ago - Transcripts

Nutex Health Earnings release: Q1 2026

Nutex Health released its Q1 2026 earnings on May 1, 2026, summarizing the period's financial results.

18 days ago - Filings

Nutex Health Quarterly report: Q1 2026

Nutex Health has published its Q1 2026 quarterly earnings report on May 1, 2026.

18 days ago - Filings

Nutex Health reports Q1 EPS $6.52 vs. $3.33 last year

Reports Q1 revenue $216.49M, consensus $227.8M. “The 2026 year has started out strong producing solid revenue of $216.5 million, net income attributable to Nutex of $46.8 million, diluted EPS of…

19 days ago - TheFly

NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

HOUSTON, April 30, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced financial results for the three months ended March 31, 2026. Nutex Health is...

19 days ago - PRNewsWire

Nutex Health Transcript: AGM 2026

The meeting covered director elections, executive compensation, and auditor ratification, with all proposals approved by the required majority. Voting results will be reported on Form 8-K within four business days.

26 days ago - Transcripts

Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call

HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatie...

27 days ago - PRNewsWire

Nutex Health Proxy statement: Proxy Filing

Nutex Health filed a proxy statement on March 13, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

Nutex Health Proxy statement: Proxy Filing

Nutex Health filed a proxy statement on March 13, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

Nutex Health Earnings Call Transcript: Q4 2025

Revenue grew 82% to $875.3M in 2025, with net income up to $70.8M and adjusted EBITDA rising 152.6%. Despite a one-time $55M Q4 revenue reduction from arbitration true-up, cash flow and patient volumes remained strong, supporting continued expansion and high patient satisfaction.

2 months ago - Transcripts

Nutex Health Earnings release: Q4 2025

Nutex Health released its Q4 2025 earnings on March 6, 2026, summarizing the period's financial results.

2 months ago - Filings

Nutex Health Annual report: Q4 2025

Nutex Health has published its Q4 2025 annual report on March 6, 2026.

2 months ago - Filings

Morning Movers: Nutex Health sinks after fourth quarter results

Futures are lower this morning with investors continuing to price the macro and geopolitical shock stemming from the rapidly escalating conflict involving Iran and its implications for global energy s...

2 months ago - TheFly

Nutex Health reports Q4 revenue $151.7M vs. $257.6M last year

Net income attributable to Nutex Health (NUTX) for the three months ended December 31, 2025 was $11.8M as compared to net income attributable to Nutex Health of $61.6M for the…

2 months ago - TheFly

Nutex Health reports Q4 EPS $10.48 vs. last year

Reports Q4 revenue $151.7M, consensus $258.82M. The company attributes the $105.9M revenue decrease primarily to two items: a one-time $55.0M cumulative true-up of arbitration claims determined inelig...

2 months ago - TheFly

Nutex Health reports 2025 EPS $10.48 vs. $9.69 in 2024

18:42 EST Nutex Health (NUTX) reports 2025 EPS $10.48 vs. $9.69 in 2024

2 months ago - TheFly

Nutex Health authorizes $25M share repurchase program

Nutex Health (NUTX) has authorized a second stock repurchase program of up to $25.0M of the company’s common stock over the next six months. The share repurchase program authorization does…

2 months ago - TheFly

NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM

FULL YEAR 2025 HIGHLIGHTS: Total revenue of $875.3 million for the year 2025 versus $479.9 million for the year 2024, an increase of 82.4% Net income attributable to Nutex Health of $70.8 million for ...

2 months ago - PRNewsWire

Nutex Health Slides: Company presentation

Nutex Health has posted slides in relation to its latest quarterly earnings report, which was published on March 5, 2026.

2 months ago - Filings

Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call

HOUSTON, Feb. 25, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatien...

2 months ago - PRNewsWire

NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON

HOUSTON, Jan. 12, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro...

4 months ago - PRNewsWire

NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO

HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micro ...

4 months ago - PRNewsWire

NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS

HOUSTON , Dec. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micr...

5 months ago - PRNewsWire

Nutex Health extends stock repurchase program

Nutex Health (NUTX) announced that its board of directors has approved an extension of the previously authorized stock repurchase program. The program, originally announced on August 14, authorized th...

5 months ago - TheFly